ACTRN12617001614381
Recruiting
未知
Early prophylactic peritoneal dialysis in infants post cardiac surgery: a randomised, open, two group trial
The Royal Children's Hospital Melbourne0 sites312 target enrollmentStarted: December 8, 2017Last updated:
Overview
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- The Royal Children's Hospital Melbourne
- Enrollment
- 312
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Randomised controlled trial
- Primary Purpose
- Treatment
- Masking
- Open (masking not used)
Eligibility Criteria
- Ages
- Days to 180 Days (—)
- Sex
- All
Inclusion Criteria
- •Infants less than or equal to 180 days of age who have had cardiac surgery (in RACHS\-1 categories 3 to 6\) with cardiopulmonary bypass will be eligible, providing they have a peritoneal dialysis catheter in place at the time of admission to ICU and are expected to be ventilated for at least 24 hours
Exclusion Criteria
- •The exclusions will be: 1\) if withdrawal of treatment is being considered 2\) infants who have already participated in the same trial during a previous cardiac surgery 3\) children already on extracorporeal membrane oxygenation (ECMO) at the time of admission from the operating theatre and 4\) infants whose parents refuse consent.
Investigators
Similar Trials
Recruiting
Not Applicable
Reduction of peritoneal dialysis-related peritonitis by dental intervention at dialysis inductioPeritoneal dialysis-related peritonitisJPRN-UMIN000028782Matsuyama Red Cross Hospital50
Completed
Not Applicable
The IDEAL Study: a clinical trial of the timing of kidney dialysis initiation on survival in subjects with chronic kidney disease.Chronic Kidney diseaseCardiac diseaseNutritionRenal and Urogenital - Kidney diseaseACTRN12609000266268Steering Committee of the IDEAL Study800
Unknown
Not Applicable
Renal Replacement Therapy in NeonatesRenal FailureNCT05456659University Hospital, Strasbourg, France72
Recruiting
Not Applicable
To study the outcome related to early (within 2-3 weeks of illness) versus delayed (in 4th week of illness) drainage of infected pancreatic fluid collections in patients with acute pancreatitisCTRI/2017/11/010476o sponsor
Active, not recruiting
Not Applicable
A Study in Renal Predialysis and Dialysis Patients of the Safety, Tolerability, and Immunogenicity of Recombinant Hepatitis B Vaccine Manufactured With a Modified Process - NDProphylactic vaccination against infection with hepatitis B virus in renal predialysis and dialysis patientsMedDRA version: 9.1Level: LLTClassification code 10038474Term: Renal insufficiencyEUCTR2006-003650-20-ITMerck and Co Inc.276